Healthcare - Drug Manufacturers - General - NASDAQ - US
$ 159.99
-2.97 %
$ 23.3 B
Market Cap
14.54
P/E
Price Target
Average
73.01%
Revenue Forecast
Estimate
0.68%
EBIT
Estimate
26.67%
Net Income
Estimate
26.28%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Biogen Inc.
Wall Street analysts predict an average 1-year price target for BIIB of $277 , with forecasts ranging from a low of $202 to a high of $342 .
BIIB Lowest Price Target
Wall Street Target
202 USD
26.26%
BIIB Average Price Target
Wall Street Target
277 USD
73.01%
BIIB Highest Price Target
Wall Street Target
342 USD
113.76%
REVENUE FORECAST
Revenue Forecast Chart BIIB
EBIT FORECAST
EBIT Forecast Chart BIIB
NET INCOME FORECAST
Net Income Chart BIIB